TCL Archive DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program October 25, 1985
TCL Archive Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting April 29, 2011